Nomura Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.5M | Buy |
43,542
+398
| +0.9% | +$255K | 0.06% | 292 |
|
|
2025
Q4 | $29.2M | Sell |
43,144
-9,958
| -19% | -$6.78M | 0.07% | 252 |
|
|
2025
Q3 | $33.9M | Sell |
53,102
-7,459
| -12% | -$4.53M | 0.09% | 233 |
|
|
2025
Q2 | $32.5M | Buy |
60,561
+1,665
| +3% | +$796K | 0.09% | 242 |
|
|
2025
Q1 | $24.7M | Sell |
58,896
-6,225
| -10% | -$2.7M | 0.08% | 251 |
|
|
2024
Q4 | $26.9M | Sell |
65,121
-343
| -0.5% | -$150K | 0.08% | 240 |
|
|
2024
Q3 | $33.1M | Sell |
65,464
-4,613
| -7% | -$2.24M | 0.1% | 205 |
|
|
2024
Q2 | $34.1M | Sell |
70,077
-45,447
| -39% | -$22.8M | 0.12% | 187 |
|
|
2024
Q1 | $62.4M | Buy |
115,524
+5,097
| +5% | +$2.79M | 0.23% | 102 |
|
|
2023
Q4 | $61.3M | Sell |
110,427
-651
| -0.6% | -$306K | 0.25% | 91 |
|
|
2023
Q3 | $48.6M | Buy |
111,078
+4,723
| +4% | +$2.36M | 0.23% | 104 |
|
|
2023
Q2 | $53.4M | Buy |
106,355
+14,107
| +15% | +$6.76M | 0.25% | 98 |
|
|
2023
Q1 | $46.1M | Buy |
92,248
+30,092
| +48% | +$14.4M | 0.24% | 98 |
|
|
2022
Q4 | $25.4M | Buy |
62,156
+2,503
| +4% | +$972K | 0.15% | 154 |
|
|
2022
Q3 | $19.4M | Sell |
59,653
-5,733
| -9% | -$2.11M | 0.12% | 186 |
|
|
2022
Q2 | $22.9M | Sell |
65,386
-9,996
| -13% | -$4.08M | 0.14% | 155 |
|
|
2022
Q1 | $41.2M | Sell |
75,382
-26,704
| -26% | -$14M | 0.22% | 100 |
|
|
2021
Q4 | $67.2M | Buy |
102,086
+519
| +0.5% | +$326K | 0.34% | 65 |
|
|
2021
Q3 | $63.2M | Buy |
101,567
+3,143
| +3% | +$2.11M | 0.36% | 68 |
|
|
2021
Q2 | $62.2M | Sell |
98,424
-21,112
| -18% | -$11.7M | 0.36% | 66 |
|
|
2021
Q1 | $58.5M | Buy |
119,536
+19,112
| +19% | +$9.58M | 0.37% | 65 |
|
|
2020
Q4 | $50.2M | Sell |
100,424
-5,499
| -5% | -$2.46M | 0.34% | 69 |
|
|
2020
Q3 | $41.6M | Buy |
105,923
+2,030
| +2% | +$751K | 0.32% | 73 |
|
|
2020
Q2 | $34.3M | Buy |
103,893
+5,411
| +5% | +$1.57M | 0.29% | 78 |
|
|
2020
Q1 | $23.9M | Sell |
98,482
-5,669
| -5% | -$1.48M | 0.25% | 87 |
|
|
2019
Q4 | $27.2M | Sell |
104,151
-28,534
| -22% | -$7.52M | 0.24% | 87 |
|
|
2019
Q3 | $36.1M | Buy |
132,685
+989
| +0.8% | +$275K | 0.34% | 70 |
|
|
2019
Q2 | $36.3M | Buy |
131,696
+109,992
| +507% | +$27.1M | 0.36% | 71 |
|
|
2019
Q1 | $4.85M | Buy |
21,704
+6,594
| +44% | +$1.36M | 0.05% | 324 |
|
|
2018
Q4 | $2.81M | Buy |
15,110
+838
| +6% | +$172K | 0.03% | 405 |
|
|
2018
Q3 | $3.56M | Sell |
14,272
-19
| -0.1% | -$4.61K | 0.03% | 388 |
|
|
2018
Q2 | $3.12M | Buy |
14,291
+1,295
| +10% | +$267K | 0.03% | 416 |
|
|
2018
Q1 | $2.49M | Buy |
12,996
+924
| +8% | +$171K | 0.03% | 455 |
|
|
2017
Q4 | $1.89M | Buy |
12,072
+86
| +0.7% | +$13.5K | 0.02% | 531 |
|
|
2017
Q3 | $1.86M | Buy |
11,986
+707
| +6% | +$112K | 0.02% | 499 |
|
|
2017
Q2 | $1.82M | Buy |
11,279
+445
| +4% | +$72.3K | 0.02% | 495 |
|
|
2017
Q1 | $1.68M | Buy |
10,834
+1,234
| +13% | +$170K | 0.02% | 522 |
|
|
2016
Q4 | $1.13M | Sell |
9,600
-290
| -3% | -$33.1K | 0.02% | 610 |
|
|
2016
Q3 | $1.11M | Buy |
9,890
+440
| +5% | +$46.4K | 0.02% | 607 |
|
|
2016
Q2 | $878K | Buy |
+9,450
| New | +$812K | 0.02% | 668 |
|
Other funds holding IDXX
VCM
VPM
Nomura Asset Management's IDXX Position: Q1 2026 in Review
Nomura Asset Management increased its Idexx Laboratories (IDXX) stake by 0.92% in Q1 2026, buying an estimated $255K and bringing the position to 43,542 shares worth $24.5M. The position accounts for 0.06% of the portfolio, ranked #292.
Nomura Asset Management first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $67.2M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Nomura Asset Management held 43,542 shares of Idexx Laboratories worth $24.5M as of Q1 2026.
- Nomura Asset Management bought 398 Idexx Laboratories shares in Q1 2026, an estimated $255K.
- Idexx Laboratories made up 0.06% of Nomura Asset Management's portfolio in Q1 2026, its #292 holding.
- Nomura Asset Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
- Nomura Asset Management's Idexx Laboratories position peaked at $67.2M in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.